Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Data show that the coronavirus disease 2019 (COVID-19) symptoms can be severe in 4% and 3% of the adolescents aged 11-15 years and ≥ 16 years, respectively. In addition, the prevalence of chronic diseases among adolescents has increased in the last years. About 20% of the adolescents have some chronic disease, resulting in increased morbidity and mortality. In march, 2020, the quarantine was officially implemented in Sao Paulo, while elective medical appointments for adolescents with chronic disease were temporarily suspended. To mitigate the deleterious effect of the social isolation on physical and mental health among these patients, this study aims to test the effects of an online, home-based, exercise training program.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention | Experimental | 10 patients from each chronic diseases conditions (1- Inflammatory bowel disease; 2- autoimmune hepatitis; 3- liver transplant; 4- renal transplant; 5- systemic lupus erythematosus; 6- juvenile dermatomyositis; 7- juvenile idiopathic arthritis) will receive an online home-based aerobic training, three times a week, during 3 months. |
|
| Control | No Intervention | 10 patients from each chronic diseases conditions (1- Inflammatory bowel disease; 2- autoimmune hepatitis; 3- liver transplant; 4- renal transplant; 5- systemic lupus erythematosus; 6- juvenile dermatomyositis; 7- juvenile idiopathic arthritis) will be advised to maintain their daily routine. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Exercise training group | Other | Online aerobic home-based exercise training, 3 times per week, during 3 months. The exercise program is composed by 3 levels (starter, intermediate and advanced) which be completed in the first, second and third month of intervention, respectively. |
| Measure | Description | Time Frame |
|---|---|---|
| Safety and efficacy of a home-based exercise training program | Semi structured interview | From baseline to 3 months of follow-up |
| Measure | Description | Time Frame |
|---|---|---|
| Patients perceptions during social isolation | Semi structured interview | From baseline to 3 months of follow-up |
| Adolescents quality of life | Quality of life will be assessed by means of Pediatric Quality of Life inventory (PedsQLTM 4.0) |
Not provided
Inclusion Criteria:
Diagnosed with either one of the following chronic conditions:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Bruno Gualano, PhD | Contact | +55 11 3061-8789 | gualano@usp.br |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Univsersity of Sao Paulo | Recruiting | São Paulo | 05508-030 | Brazil |
Not provided
| ID | Term |
|---|---|
| D002908 | Chronic Disease |
| D051436 | Renal Insufficiency, Chronic |
| ID | Term |
|---|---|
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D051437 | Renal Insufficiency |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| From baseline to 3 months of follow-up |
| Disease activity | Will be assessed by means of a visual analog scale (from 0 - no disease activity) to 10 - maximum disease activity). | From baseline to 3 months of follow-up |
| Disease overall assessment | Will be assessed using the visual analog scale from 0 (very good condition) to 10 (very poor condition). | From baseline to 3 months of follow-up |
| Strengths and difficulties | Will be assessed by means of Strengths & Difficulties Questionnaires | From baseline to 3 months of follow-up |
| D007674 | Kidney Diseases |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |